- Home
- EDHL vs ACHV Comparison
EDHL vs ACHV Comparison
Compare EDHL & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDHL
- ACHV
- Stock Information
- Founded
- EDHL 2021
- ACHV N/A
- Country
- EDHL Hong Kong
- ACHV United States
- Employees
- EDHL N/A
- ACHV N/A
- Industry
- EDHL
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EDHL
- ACHV Health Care
- Exchange
- EDHL NYSE
- ACHV Nasdaq
- Market Cap
- EDHL 137.6M
- ACHV 131.2M
- IPO Year
- EDHL 2025
- ACHV N/A
- Fundamental
- Price
- EDHL $0.75
- ACHV $2.68
- Analyst Decision
- EDHL
- ACHV Strong Buy
- Analyst Count
- EDHL 0
- ACHV 3
- Target Price
- EDHL N/A
- ACHV $14.33
- AVG Volume (30 Days)
- EDHL 3.6M
- ACHV 2.0M
- Earning Date
- EDHL 01-01-0001
- ACHV 08-07-2025
- Dividend Yield
- EDHL N/A
- ACHV N/A
- EPS Growth
- EDHL N/A
- ACHV N/A
- EPS
- EDHL 0.14
- ACHV N/A
- Revenue
- EDHL $2,761,798.00
- ACHV N/A
- Revenue This Year
- EDHL N/A
- ACHV N/A
- Revenue Next Year
- EDHL N/A
- ACHV N/A
- P/E Ratio
- EDHL $5.24
- ACHV N/A
- Revenue Growth
- EDHL N/A
- ACHV N/A
- 52 Week Low
- EDHL $0.60
- ACHV $1.84
- 52 Week High
- EDHL $6.88
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- EDHL N/A
- ACHV 48.14
- Support Level
- EDHL N/A
- ACHV $2.58
- Resistance Level
- EDHL N/A
- ACHV $2.77
- Average True Range (ATR)
- EDHL 0.00
- ACHV 0.18
- MACD
- EDHL 0.00
- ACHV 0.05
- Stochastic Oscillator
- EDHL 0.00
- ACHV 78.48
About EDHL EVERBRIGHT DIGITAL HOLDING
Everbright Digital Holding Ltd is an integrated marketing solutions provider in Hong Kong that is involved in the metaverse and related technologies, and is providing one-stop digital marketing services for the process of enterprise development. Its digital marketing solutions include metaverse stimulation, virtual reality (VR) and augmented reality (AR) design and creation, creative event planning and management, IP character creation and social media marketing.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.